Imagene AI Announces Collaboration with Daiichi Sankyo to Advance Multimodal Biomarker Discovery in Oncology
Collaboration leverages Imagene’s OI Suite, powered by CanvOI and a large-scale multimodal real-world data lake, alongside Composite Continuous Scoring to strengthen biomarker-driven decisions. April 9, 2026 Imagene AI, a pioneer in multimodal AI for precision oncology, today announced a collaboration with Daiichi Sankyo (TSE: 4568) to advance biomarker discovery and response prediction in oncology drug […]
Imagene AI and Shaare Zedek Medical Center Form Strategic Data-AI Collaboration to Scale Oncology Research and Care
The collaboration combines Shaare Zedek’s real-world data and clinical expertise with Imagene AI’s Oncology Intelligence Suite to advance biomarker discovery and accelerate precision cancer care. October 29, 2025 [NewsWire] Imagene AI, a pioneer in multimodal foundation models for precision oncology, and Shaare Zedek Scientific, the innovation arm of Shaare Zedek Medical Center, today announced a […]
Imagene AI Launches the Oncology Intelligence (OI) Suite Discovery Program at Oracle AI World
OI Suite Discovery Program launches with complimentary access for researchers in biopharma companies and academic centers to accelerate biomarker discovery through an intuitive, no-code interface. CanvOI, running on Oracle Cloud Infrastructure (OCI), is now trained on more than 1.5 million biopsy images across 40+ organs and designed to perform in small early-phase cohorts. October […]